OVARIAN-CARCINOMA - A REVIEW OF THE SIGNIFICANCE OF FAMILIAL RISK-FACTORS AND THE ROLE OF PROPHYLACTIC OOPHORECTOMY IN CANCER PREVENTION

被引:0
|
作者
NGUYEN, HN [1 ]
AVERETTE, HE [1 ]
JANICEK, M [1 ]
机构
[1] DIV GYNECOL ONCOL, MIAMI, FL USA
关键词
OVARIAN CANCER; FAMILY HISTORY; HEREDITARY CANCER SYNDROME; PROPHYLACTIC OOPHORECTOMY;
D O I
10.1002/1097-0142(19940715)74:2<545::AID-CNCR2820740204>3.0.CO;2-Q
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Women with a family history of ovarian cancer are at increased risk of ovarian cancer. Prophylactic oophorectomy(PO) remains the only effective method of ovarian cancer prevention. This study reviewed current data on the significance of family history and how prophylactic oophorectomy should be used in different risk groups. Approximately 7% of ovarian cancer patients have a positive family history of whom 3-9% may eventually manifest certain hereditary cancer syndromes. Women in direct genetic lineage of family cancer syndromes have up to a 50% lifetime risk of ovarian cancer. Because of the high risk, PO is indicated for women with familial cancer syndromes after childbearing or between the ages of 35-40 at the latest. The majority of women with a positive family history of ovarian cancer do not have one of the recognized syndromes. Women with one or two affected relatives have an increased lifetime risk of ovarian cancer from a baseline of 1.6 to 5-7%. This risk is not high enough to warrant PO for a large number of women. After being properly informed, the patient still chooses surgical prevention, she then receives PO. For women without a family history of ovarian cancer, the role of PO remains controversial. Assuming an annual incidence of 22,000 new cases of ovarian cancer, it is estimated that at least 1000 may be prevented if PO is diligently practiced during hysterectomy. Despite ovarian and breast cancer prevention, PO would lead to shorter life expectancy if estrogen therapy compliance were less than perfect. Thus, the decision on PO as a concurrent procedure should depend on the individual patient and her ability to comply with lifelong estrogen therapy.
引用
收藏
页码:545 / 555
页数:11
相关论文
共 50 条
  • [31] FAMILIAL AGGREGATION OF RISK-FACTORS FOR BREAST-CANCER
    ROSENBLATT, KA
    MORABIA, A
    IMREY, P
    STEWART, W
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1995, 141 (11) : S32 - S32
  • [32] FAMILIAL RISK-FACTORS FOR MALE BREAST-CANCER
    ROSENBLATT, KA
    THOMAS, DB
    STEMHAGEN, A
    SATRARIANO, W
    CURNEN, M
    MCTIERNAN, A
    AUSTIN, DF
    ISSACSON, P
    GREENBERG, R
    KEY, CR
    WEST, D
    KOLONEL, LN
    STALSBERG, H
    AUSTIN, MA
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1989, 130 (04) : 812 - 812
  • [33] MULTIPLE RISK-FACTORS AND FAMILIAL AGGREGATION OF NASOPHARYNGEAL CARCINOMA IN TAIWAN
    CHEN, CJ
    LIANG, KY
    CHANG, AS
    ANTICANCER RESEARCH, 1988, 8 (05) : 1146 - 1146
  • [34] ENVIRONMENTAL CANCER RISK-FACTORS - A REVIEW
    TOMATIS, L
    ACTA ONCOLOGICA, 1988, 27 (05) : 465 - 472
  • [35] Prophylactic and Risk-Reducing Bilateral Salpingo-oophorectomy: Recommendations Based on Risk of Ovarian Cancer
    Blank, Stephanie V.
    OBSTETRICS AND GYNECOLOGY, 2011, 117 (02): : 404 - 404
  • [36] Prophylactic and Risk-Reducing Bilateral Salpingo-oophorectomy Recommendations Based on Risk of Ovarian Cancer
    Berek, Jonathan S.
    Chalas, Eva
    Edelson, Mitchell
    Moore, David H.
    Burke, William M.
    Cliby, William A.
    Berchuck, Andrew
    OBSTETRICS AND GYNECOLOGY, 2010, 116 (03): : 733 - 743
  • [37] Prophylactic surgery and other strategies for reducing the risk of familial ovarian cancer
    Elizabeth Swisher
    Current Treatment Options in Oncology, 2003, 4 (2) : 105 - 110
  • [40] RISK-FACTORS FOR EPITHELIAL OVARIAN-CANCER IN ITALY
    FRANCESCHI, S
    LAVECCHIA, C
    HELMRICH, SP
    MANGIONI, C
    TOGNONI, G
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1982, 115 (05) : 714 - 719